Biolojic Design, Ltd.

Biolojic Design, Ltd. company information, Employees & Contact Information

Biolojic Design makes developable, active human antibodies directed against functional epitopes, including targets for which existing technologies fail.

Company Details

Employees
94
Founded
-
Address
12 Hamada St, Rehovot,1 0000,israel
Email
ad****@****jic.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
REHOVOT, 1
Looking for a particular Biolojic Design, Ltd. employee's phone or email?

Biolojic Design, Ltd. Questions

News

Teva and Biolojic Design Initiate IND-enabling Studies of - GlobeNewswire

Teva and Biolojic Design Initiate IND-enabling Studies of GlobeNewswire

Unlocking the potential of smart antibodies - Drug Target Review

Unlocking the potential of smart antibodies Drug Target Review

Biolojic Design Appoints Neal Curran as Chief Business Officer - GlobeNewswire

Biolojic Design Appoints Neal Curran as Chief Business Officer GlobeNewswire

Biolojic Design lands drug discovery collaboration with Merck potentially worth up to 346 million euros - CTech

Biolojic Design lands drug discovery collaboration with Merck potentially worth up to 346 million euros CTech

Biolojic Design signs Merck deal potentially worth $373M - Unpacked

Biolojic Design signs Merck deal potentially worth $373M Unpacked

First-Ever Computationally Designed Antibody, Created by Biolojic Design, Entering Human Clinical Trial In Cancer Patients - PR Newswire

First-Ever Computationally Designed Antibody, Created by Biolojic Design, Entering Human Clinical Trial In Cancer Patients PR Newswire

Biolojic Design Joins Johnson & Johnson Innovation - JLABS - GlobeNewswire

Biolojic Design Joins Johnson & Johnson Innovation - JLABS GlobeNewswire

Biolojic Design Appoints Ronald Herbst, Ph.D., as Chief Scientific Officer - PR Newswire

Biolojic Design Appoints Ronald Herbst, Ph.D., as Chief Scientific Officer PR Newswire

Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany - GlobeNewswire

Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany GlobeNewswire

Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases - GlobeNewswire

Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases GlobeNewswire

Biolojic Design Enters a Research Collaboration and License Option Agreement with Nektar Therapeutics to Develop Computationally Designed Antibodies Against a Novel Target for the Potential Treatment of Autoimmune Disease - GlobeNewswire

Biolojic Design Enters a Research Collaboration and License Option Agreement with Nektar Therapeutics to Develop Computationally Designed Antibodies Against a Novel Target for the Potential Treatment of Autoimmune Disease GlobeNewswire

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant